© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Many years have passed since Trilostane broke onto the pharmaceutical scene. Researchers started working on steroid biosynthesis inhibitors in the 1960s, aiming to manage diseases linked to excessive hormone production. Trilostane gained traction in the late 1970s after scientists recognized its potential for treating conditions like Cushing’s syndrome and certain types of breast cancer. It played a major role before newer drugs entered the picture. I’ve seen animals benefit from its use in veterinary medicine for years, which all started from those early chemical breakthroughs and persistent investigation into steroid metabolism.
Trilostane goes by many names, such as Modrastane and WIN 24540, and several trade names. It is usually found as a white to off-white crystalline powder. The substance comes packaged in tightly sealed containers to avoid moisture and light, which could harm its stability. Pharmacies supply it in capsules or compounding powders for different dosing requirements. Before Trilostane, doctors relied more heavily on surgery or radiation to manage certain endocrine diseases, but this medication made things a bit easier for many patients and their pets.
On the chemical side, Trilostane stands as a synthetic steroid with a molecular formula of C20H27NO3 and a molecular weight of 329.43 g/mol. The melting point typically ranges between 261 and 263°C. Most producers note that it’s pretty insoluble in water but dissolves well in methanol, ethanol, and chloroform. You’ll spot a slightly bitter taste if you happen to test the contamination on gloved hands, so I always double-check personal protective equipment. Stable under normal laboratory conditions, it degrades under strong acid or base, so storage and usage guidelines help keep it effective.
Technical data sheets lay everything out in detail. Purity should hit at least 98%, with strict limits on moisture and heavy metals. The assay for active pharma content isn’t just a formality—any dip below threshold means the treatment loses precision. Labels carry batch numbers, expiration dates, and clear hazard warnings. Safe handling instructions appear upfront, not buried in a pamphlet nobody reads. Proper labeling means quick supply identification, which matters in clinics or operating rooms when dosage needs arise suddenly.
Making Trilostane involves several steps, mostly working through hydrogenation and esterification starting from pregnenolone. Skilled chemists use selective reduction and protection tactics to shape the steroid’s skeleton without breaking it apart. Some labs use chromatography to purify the crude product, focusing on getting rid of related analogs and reaction leftovers. Even a small contaminant can interfere with drug safety, so the final steps include vacuum drying and sealed packaging, with quality assurance teams confirming the right compound and purity with spectroscopy.
Trilostane is best known for its interaction with 3β-hydroxysteroid dehydrogenase, blocking the formation of multiple steroids. Chemists have tweaked its structure over the years—adding side chains, flipping ring configurations—to try and improve activity or cut down unwanted side effects. These modifications often stem from trial and error. Laboratories regularly push for analogs that ramp up potency or lower toxicity, but only a handful make it through to large-scale use. The structure-activity relationships uncovered in this research feed back into the long, slow process of drug improvement.
You’ll see Trilostane under several listings: Modrastane, WIN 24540, and 4α,5α-Epoxy-17β-hydroxy-3-oxoandrostan-2-carboxamide, among others. Popular brand names have come and gone, but ‘Trilostane’ usually stands out. Each manufacturer stamps its own approval code or batch label. In veterinary circles, the name ‘Vetoryl’ dominates. Knowing these alternate names matters if you’re scanning product directories or safety databases because a single letter can spell out an entirely different compound with different safety profiles.
Clinical and industrial safety protocols focus on limiting accidental exposure. Handlers wear gloves, safety glasses, and masks to prevent inhalation or skin contact. Regulatory agencies demand that manufacturing operators install closed systems, keeping powder dust out of the air. Direct exposure causes irritation to skin and eyes, so first aid procedures stay posted in labs and veterinary clinics. There’s a clear requirement for traceability: every bottle gets logged as it’s dispensed, ensuring zero confusion in multi-patient environments where dosing errors can have serious fallout.
Doctors have prescribed Trilostane mainly for Cushing’s syndrome, especially when surgery isn’t possible. Endocrinologists use it for controlling overactive adrenal glands, and oncologists experimented with it for breast cancer before more targeted therapies appeared. Veterinarians found it particularly useful for managing dogs with hyperadrenocorticism. Regulations differ by country: some regions approve it for humans, some restrict use to animals only. Still, Trilostane keeps turning up in clinics dealing with tough hormonal conditions that don’t respond to standard therapies.
Research teams keep digging into how Trilostane interacts at the molecular level, trying to fine-tune its impact or expand its uses to other hormonal diseases. Scientists conduct clinical trials to track long-term effects and scan for clues about resistance or dosage optimization. New delivery forms, including long-acting injectables, attract attention for improving treatment convenience. With competition from newer steroid synthesis inhibitors, development focuses on comparative safety, ease of use, and how the drug fits into multi-drug regimens for difficult endocrine disorders.
Results from toxicity studies point to gastrointestinal upset, liver stress, and possible adrenal suppression if misused or overdosed. Dogs on Trilostane have shown some appetite and energy dips, while humans, especially at higher doses, risk cortisol deficiencies. Preclinical tests look for carcinogenic and teratogenic signals, with regulations requiring rigorous batch-by-batch scrutiny. Safety teams focus on minimizing exposure during production and compounding because accidental inhalation and skin contact can cause health concerns after repeated exposures. This isn’t just a box to check; it matters for staff who handle the drug every day.
Trilostane may not be the latest innovation on pharmacy shelves, but it fills a gap for people and animals whose conditions resist curative surgery. I see a place for it in rare disease management, especially as genetic studies clarify exactly which pet or patient will respond best. Personalized medicine might boost its relevance, as doctors and veterinarians tailor dosage and duration using genetic markers. Ongoing research into safer analogs, better delivery systems, and expanded disease targets keeps Trilostane perched in a spot where practical treatment needs outweigh trends. This enduring utility often means more than headlines about breakthrough therapies.
Trilostane matters a lot in the world of hormone-related health problems. This medication works by blocking a step in the body’s process for making certain hormones. These hormones, including cortisol and aldosterone, play big roles in how the body handles stress, salt, and water. Most folks think of trilostane as a tool for treating diseases like Cushing’s syndrome, especially in animals such as dogs, but people can have some exposure to it as well.
In terms of dogs, especially older ones, Cushing’s disease tends to sneak up with symptoms like a pot-bellied look, increased thirst, and hair loss. That’s not just hard for the dog; it’s rough on the owner, watching an active friend slow down or get sick. Trilostane gives many pet owners a chance to see their dogs come back to their old selves. Some get their appetite and energy back, and the thirst settles down. These changes can mean a huge improvement in quality of life. According to a study published in the Journal of Veterinary Internal Medicine, trilostane tends to manage symptoms without a lot of scary side effects when vets monitor things closely. That means fewer vet visits for the bad days and more time just enjoying moments with a pet.
For humans, trilostane was at one time a treatment for Cushing’s syndrome and some forms of breast cancer. Cushing’s syndrome brings tough problems: rapid weight gain, high blood pressure, and muscle loss. Trilostane blocks the formation of cortisol, making it easier for doctors to help the body get back toward normal. It’s not a magic bullet and doesn’t work for every single patient, but research way back in the 1980s showed trilostane could control cortisol levels and give people some relief. Over time, newer treatments have stepped in with fewer risks, but trilostane showed what was possible with targeted hormone-blocking strategies.
Medication like trilostane doesn’t work the same for every dog or person. One of the biggest problems happens when the dose goes too high and the body suddenly drops cortisol too low. That can send someone or a pet into a crisis—a problem called Addisonian crisis. It’s a big reason trilostane should only be used with steady follow-up and regular testing. Vets and doctors rely on lab checks to make sure patients aren’t swinging too far in either direction. People who ignore the need for repeat bloodwork risk ending up in a worse spot than they started.
Access to good veterinary care often decides whether pets benefit from trilostane. In many rural areas and low-income households, even getting a diagnosis for Cushing’s disease takes time and money. The medication isn’t cheap either. Some families turn to online pet forums or crowdfunding for help with the cost. Insurance for pets can soften the blow, but it’s not available everywhere and not every policy covers these medications.
More education around hormone diseases and early warning signs helps both people and animals get the treatment they need before things get severe. Pharmacies and pet groups can work with veterinarians to make drugs like trilostane more affordable. As research brings out new hormone blockers or easier monitoring options, outcomes get better for those fighting Cushing’s and other similar disorders. Reliable access to these advancements takes the support of public policy and community action.
Doctors often prescribe Trilostane for dogs with Cushing’s disease. This medication helps manage hormone imbalance in the adrenal glands. I’ve talked with more than a few pet owners who saw their dog’s symptoms ease up after starting Trilostane. Still, every drug brings its own risks, especially the kind that targets hormones.
After starting Trilostane, some dogs lose their appetite or become lethargic. Vomiting and diarrhea turn up fairly often too. My own neighbor gave her terrier this drug and saw the poor dog rest less and struggle with nausea for a few weeks. The vet guided her through slower dose adjustments, which helped. Most dogs tolerate mild discomfort for a few days, but things can get serious quickly if pet owners miss the signs.
Low cortisol levels in the body can trigger serious trouble. Dogs might collapse, act disoriented, go off food completely, or vomit repeatedly. These signs sometimes point to an Addisonian crisis—a medical emergency where hormone levels drop too low. Left untreated, a crisis can turn fatal. I’ve seen owners wait too long, thinking a little tiredness doesn’t mean much. Prompt veterinary care makes all the difference in outcomes.
The emotional toll matters too. Chronic illnesses strain both pets and their families. Medication side effects disrupt routines, add expense, and cause stress. Managing doses and tracking subtle changes in behavior gets exhausting. It’s important not to downplay the impact long-term Trilostane therapy has on daily life.
Vets order frequent blood tests for dogs on Trilostane. Regular checks allow early detection if hormone levels drop too far. Some clinics monitor every three months, others sooner if side effects show up. These tests catch slight problems before they turn into big ones. I’ve heard owners grumble about the costs, and who can blame them? But saving on check-ups risks bigger medical bills later.
Trilostane may cause skin problems such as thinning fur or pigmentation changes. These aren’t always dramatic, but sometimes they point to underlying issues. In rare cases, dogs develop liver inflammation or kidney problems. Quick identification and stopping the drug usually resolves these complications. A few unlucky pets don’t recover fully, so regular lab work is critical.
Dosage control stands front and center. Vets usually start low and increase slowly. Never change a dose or skip a pill without professional guidance. Reporting any changes—no matter how small—helps adjust treatment before things get out of hand. In my experience, the best outcomes come when owners and vets keep clear, open communication.
Trilostane gives many pets with Cushing’s a better shot at a normal life. Like all medicine, it has trade-offs. Education, frequent monitoring, and fast response to problems keep risk in check. Owners who learn the facts and keep close contact with their vet often see their pets live happier, healthier lives despite chronic disease.
Giving a pet Trilostane isn’t just about tossing a pill and calling it a day. I’ve talked with veterinarians, lived with aging dogs, and seen firsthand what goes wrong when attention drops. Trilostane treats dogs with Cushing’s disease—a condition that turns their body into a hormonal roller coaster. The drug blocks the production of cortisol, and cortisol does a lot for the body. Give too little, and symptoms stick around: muscle loss, panting, and thirst that never ends; go too high, and things flip to dangerous low cortisol, leaving pets weak or even facing shock.
Handing over dosing to guesswork is risky. Pet weight changes, and response shifts from dog to dog. Labs often do the legwork—blood tests usually guide a vet in fine-tuning the dose. So each dose must match the current weight, stage of illness, and how the dog responds. Some dogs react fast; some barely budge. Without regular monitoring, you’re gambling with their health.
Vets choose the form based on the pet. I’ve seen Trilostane dispensed as capsules, tablets, or specially compounded liquid for the tough cases. Crushing capsules for food might seem easier, but unless the pharmacist okays it, medicine breaks down or delivers unevenly. Even something simple, like if the dog gobbles up breakfast before or after taking the drug, impacts absorption. Controlled, consistent routines lower the risk of wild swings in cortisol.
Feeding time connects with Trilostane. Many doctors recommend giving it with food for steadier uptake. Skipping food can slow things down, so sticking to the same feeding and dosing schedule every day grounds the process. If you forget and skip a dose, don’t just double up—always ask your vet what to do.
Nobody wants to see their pet get sicker from the very medicine meant to help. Owners should be ready to watch for sudden changes. Lethargy, vomiting, diarrhea, poor appetite, or collapse need fast action—a vet should know right away. Too much Trilostane can flip Cushing’s into something eerily similar to Addison’s disease, a far more dangerous lack of cortisol.
I’ve learned to keep a journal—write down appetite, activity, behavior, water intake, and any strange symptoms each day. Noting these changes doesn’t just help the vet; it often catches brewing problems before they explode. Friends with Cushing’s dogs often compare notes; support circles help spot trends that might sneak past distracted eyes.
Caring for a pet on Trilostane is real commitment. Skipping bloodwork ends up being the fast track to trouble. At-home checks, routine updates with your vet, and letting kids or other family members know not to feed the dog outside of scheduled mealtimes, all play a part. Even treat time can get tricky, so swapping traditional snacks for approved low-fat alternatives helps keep the diet stable.
Long-term, working as a team with your clinic keeps pets living comfortably. Trilostane isn’t a simple fix, but with daily care and close observation, dogs with Cushing’s can keep joy in their lives. The process takes patience, precision, and a willingness to reach out for help when things feel uncertain.
Medication interactions aren't something to ignore. I’ve watched a close friend’s dog take trilostane for Cushing’s disease, and I learned that mixing the wrong meds or skipping important checks can cause big trouble. Trilostane helps control the symptoms of this disease, but it isn’t just a switch you flick. With trilostane, the margin for mistakes can feel razor-thin.
Some pets just aren’t the right candidates for trilostane. Veterinarians know that animals with liver or kidney problems struggle to process medicines. Trilostane puts extra pressure on those organs, creating extra risk. I read about a cat whose liver just couldn’t keep up. The side effects were bad — fatigue, digestive issues, and lab numbers that hit the danger zone. Giving trilostane to an animal with substantial kidney or liver disease means running the gauntlet, where complications can come on suddenly.
Addison’s disease stands out as a major red flag, too. If an animal already has low adrenal activity, trilostane can knock those hormone levels even lower. That can tumble an animal into a crisis, and labs will show potassium and sodium readings that look out of control. My vet explained how quickly things can head south if the wrong diagnosis gets trilostane involved.
I’ve noticed that trilostane doesn’t mix well with some common meds. ACE inhibitors (like enalapril for heart problems) and diuretics often get prescribed for other conditions in older animals. Both can send potassium levels higher. Added together with trilostane, which also bumps potassium, this combo can cause dangerous heart rhythms. What shocks me is how easy it is to miss this risk without steady lab checks.
Steroids and trilostane lock horns, too. Steroids help animals in Addisonian crisis, but trilostane works by blocking steroid production. Mixing the two sometimes makes treatment less effective. I know some vets try to balance this mix, but it takes careful timing.
Ketoconazole also deserves a mention. It’s an antifungal that interferes with the same adrenal pathway as trilostane. Putting both in play increases the chance of adrenal insufficiency, as both suppress cortisol production. For me, the lesson is clear — combos should never come from guesswork or assumptions.
Good outcomes come from oversight. My friend’s vet insisted on regular blood work and urine checks. These caught issues before they snowballed. The best results happened when everyone paid attention to food, symptoms, and changes in mood or appetite. Families and vets communicated quickly, and treatments adjusted before things boiled over.
Education also makes a difference. I’ve seen pet owners pick up on early signs of trouble after reading real stories. Knowing the warning signals, like sudden vomiting, diarrhea, loss of appetite, or tiredness, means help arrives sooner.
Careful vet partnerships and honest reporting at home kept things safer for my friend’s dog. Drug interactions and medical contraindications with trilostane carry serious weight, but people who stay involved create a buffer against worst-case scenarios. If a pet takes trilostane, regular tests and a healthy respect for potential risks help treatments do more good than harm.
Anyone with a pet facing Cushing’s disease has probably heard the name “Trilostane” from a vet at some point. Back in the clinic, the worry is loud and clear: Will this pill help my dog get back to chasing balls and wagging tails? Living through those daily ups and downs with my own old mutt, I wanted answers that actually mattered. Not numbers from a lab. Not statistics from a brochure. Just: how fast before my pet starts feeling better?
Trilostane blocks something called 3β-hydroxysteroid dehydrogenase. That’s the mouthful of a name for the enzyme pets use to build cortisol, the hormone that gets too high with Cushing’s. Less cortisol, less thirst, less peeing, more energy. Simple on paper. Getting real results, that’s a path with turns and bumps.
Some owners have watched their pets perk up after a week on Trilostane. Appetite balances out. Drinking goes back to normal. Fur stops coming out in clumps. I’ve spoken to folks who saw a spark return to their old lab after four or five days—a kind of awakening. I’ve also met people waiting two, three weeks before the effect sets in. The medical papers back this up. A 2020 study in the Journal of Veterinary Internal Medicine tracked over a hundred dogs. Most saw their symptoms improve within two weeks, and a significant jump in energy at the one-week mark.
Every animal is different. Age, how severe the disease has gotten, the dose, and even little things like kibble flavor can play a part. The medication doesn’t sweep symptoms away in a single afternoon, but within that first month there’s usually a shift that owners notice. Sometimes quieter, more subtle than they’d hoped, but moving in the right direction nonetheless.
People need real honesty here. Trilostane can cause cortisol to drop too low, sometimes throwing pets into a slump. Lethargy, vomiting, shakiness—those is the red flag moments. Getting bloodwork is more than chore or expense; this checks if the medication is actually working, and keeps pets out of trouble. Ignoring those can lead to serious setbacks. Vets often tweak the dose or check blood at two weeks, then every few months.
High price tags weigh on a lot of families. Trilostane isn’t cheap. I’ve watched owners split pills, drive hours for clinics with better prices, or crowdsource advice out of pure desperation. Talking frankly with a vet, asking about compounding pharmacies, or even non-profit help matters more than pride. Nobody likes to admit money worries, but the safety net of a good support system keeps pets on their medication longer.
Better, cheaper testing could make a big difference: less stress, faster results. If more clinics ran owner support groups or workshops for managing chronic pet diseases, nobody would feel so lost. Reliable online guides, written by vets in plain talk, would go a long way to ease the confusion and fears that come with each dose. I would love to see more research—on whether dose adjustment by symptoms alone works as well as bloodwork—because nobody wants to take a gamble with their best friend.
Most owners don’t want miracles, just those small wins. For most pets, Trilostane makes them possible. Patience, teamwork, and honest information bring back those tail wags and happy sighs, one dose at a time.
| Names | |
| Preferred IUPAC name | (4α,5α,17β)-4,5-Epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile |
| Other names |
Modrastane NSC-122198 WIN-24540 |
| Pronunciation | /trʌɪˈlɒsteɪn/ |
| Identifiers | |
| CAS Number | 13647-35-3 |
| 3D model (JSmol) | `3DModel = "JSmol('C[C@@H](O)[C@H]1CC2=CC(=O)CCC2C2CCC1C2(C)C', options)"` |
| Beilstein Reference | 3564106 |
| ChEBI | CHEBI:9648 |
| ChEMBL | CHEMBL1427 |
| ChemSpider | 3795 |
| DrugBank | DB01168 |
| ECHA InfoCard | 100.166.785 |
| EC Number | 1.1.1.146 |
| Gmelin Reference | 69204 |
| KEGG | D08668 |
| MeSH | D016679 |
| PubChem CID | 657297 |
| RTECS number | BP8M303H6K |
| UNII | 0M7OB88L7I |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C20H27NO3 |
| Molar mass | 329.428 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.17 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 2.67 |
| Vapor pressure | 1.04E-14 mmHg at 25°C |
| Acidity (pKa) | 12.16 |
| Basicity (pKb) | 2.78 |
| Magnetic susceptibility (χ) | -84.3e-6 cm³/mol |
| Refractive index (nD) | 1.510 |
| Dipole moment | 4.2 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 354.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | –8019 kJ/mol |
| Pharmacology | |
| ATC code | **G03GA06** |
| Hazards | |
| Main hazards | May damage fertility or the unborn child. Causes skin irritation. Causes serious eye irritation. |
| GHS labelling | GHS labelling of Trilostane: `"Warning; H302; H361; P201; P202; P264; P270; P308+P313; P405; P501"` |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: H302, H360FD |
| Precautionary statements | P264, P270, P280, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-2-1-0 |
| Flash point | 86.5 °C |
| Autoignition temperature | Autoignition temperature: 400°C |
| Lethal dose or concentration | LD50 (oral, rat): >1000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral >1000 mg/kg |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Trilostane: Not established |
| REL (Recommended) | 30–40 mg/m² PO q24h |
| Related compounds | |
| Related compounds |
Stanozolol Epostane Oxandrolone Formestane |
